LiverUnit_VallHebron
730 posts
LiverUnit_VallHebron
@LHuvh
Your liver, our problem, your solutions. Fighting all liver diseases with enthusiasm and talent. This is not an institutional account.
Barcelona Katılım Haziran 2018
105 Takip Edilen512 Takipçiler
And dinner of the Spanish Portal Hypertension (Fraternity) Group
👏👏👏🔝🔝🔝
@AEEH2026
@AEEHLiver @BavenoCoop @CIBER_ISCIII @VHIR_
English
Many fantastic scientific activity from members of our @LHuvh during the #AEEH2026
Congratulations to the team
👏👏👏
@AEEHLiver @CIBER_ISCIII @VHIR_
English
LiverUnit_VallHebron retweetledi
💡 The ANTICIPATE-NASH models outperform histology in predicting clinical events in advanced MASLD, enabling better patient risk stratification for clinical care and trial selection. Read the full study here: ow.ly/27TO50Y7EO7
🖋️ @JuanAbraldes
English
Finally our @LHuvh @JuanAbraldes @salvopetta @GileadSciences paper on @AGA_Gastro showing that #ANTICIPATE-NASH predicts and stratifies clinicals events ⬆️⬆️better than #histology #TLM25
@BavenoCoop @VHIR_ @CIBER_ISCIII @AASLDtweets
sciencedirect.com/science/articl…
English
Delayed but not forgotten, celebrating ending the residence with our @LHuvh senior residents in hepatology.
Some will stay, some will go away, but remembered will be all.
@vallhebron @VHIR_ @AEEHLiver
English
Excelent editorial by @ldcastera in @AGA_Gastro about our coming paper @LHuvh
@JuanAbraldes @salvopetta showing that #ANTICIPATE-NASH predicts and stratifies clinicals events better than #histology
@BavenoCoop @VHIR_ @CIBER_ISCIII
gastrojournal.org/article/S0016-…
English
The 25 kPa for #CSPH is valid, buy the #ANTICIPATE+/- NASH 75% is better. A new ruling in criterion for CSPH by the @BavenoCoop:
Refining the Baveno VII criteria for clinically significant portal hypertension- Journal of Hepatology
journal-of-hepatology.eu/article/S0168-…
@LHuvh @VHIR_ @ciberehd
English
LiverUnit_VallHebron retweetledi
Original Article
Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death
Vutien et al.
#LiverX
tinyurl.com/4v7r4cev
English
LiverUnit_VallHebron retweetledi
Ciao Jaume, goodbye cariño mio. You have been such a special and wonderful man and I will love you forever.
English
The Liver Unit @LHuvh of HUVH @vallhebron wants to pay tribute to Jaime Bosch. A model for hepatologists and a true friend . The portal hypertension gang @BavenoCoop is now orphan.
Ramon Bataller@rabataller
With deep sadness, we share the passing of Dr. Jaime Bosch — a visionary researcher, passionate physician, and cherished friend. Widely regarded as the father of portal hypertension, the Liver Unit of Barcelona will always be indebted to his immense legacy.
English
LiverUnit_VallHebron retweetledi
New research - Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial
thelancet.com/journals/langa…
#LiverTwitter #MedTwitter
English
Mar Riveiro @mar_riveiro from our @LHuvh preventing a multi center study on CDKi-induced liver injury
English
LiverUnit_VallHebron retweetledi
📊 Validation of Baveno VII criteria for non-invasive diagnosis of clinically significant portal hypertension: systematic review and individual patient data meta-analysis
#POSTER WED-512-YI by Juan Bañares (@vallhebron) #EASL2025 @ef_clif @easlnews
English
LiverUnit_VallHebron retweetledi
⏰ Save the date!
Join us for the Summer Edition of the @LiverSeminars, taking place June 10–11 at @idibaps #Barcelona!
Two days of insightful talks, scientific exchange, and the latest in liver research.
Stay tuned for further info!
English